Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately results in significant reduction in body mas